PARP1 and neoplasm: To further investigate the correlation between injected mass, [18F]olaparib tumour uptake and target expression, we employed immunohistochemistry to semi-quantitatively compare PARP1, 2, and 3 expression in U87MG xenografts (Fig. 4).